LimmaTech Biologics AG

📍 Schlieren, Switzerland🗓 Founded 2015👥 46 employees💰 Last funded Jun 2015
Biotechnology Research🌐 lmtbio.com
Website LinkedIn
LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in LimmaTech Biologics AG?
LimmaTech Biologics AG has 1 investors on record on gritt.io, including 1 early-stage backers.
When did LimmaTech Biologics AG last raise funding?
The most recent investment in LimmaTech Biologics AG recorded on gritt.io was in June 2015.
When was LimmaTech Biologics AG founded?
LimmaTech Biologics AG was founded in 2015.
What industry is LimmaTech Biologics AG in?
LimmaTech Biologics AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LimmaTech Biologics AG based?
LimmaTech Biologics AG is headquartered in Schlieren, Switzerland.